ALSO NOTED: Tenet reports $31M loss for quarter; FDA rules against broader Fentora use; and much more...

> Tenet has reported a $31 million loss for the first quarter of this year. FierceHealthFinance

> An FDA panel has decided against broadening the use of the painkiller Fentora for the time being, though observers predict that the agency will eventually cave. FiercePharma

> In another FDA note, the agency has ordered drugmaker Merck to fix problems with its main vaccine plant in West Point, PA. FierceVaccines

> The National Council for Prescription Drug programs is launching a new database which it says will make claims processing easier and reimbursement faster. Article

And Finally...  In this culture, it's normal to drop babies off of buildings. But should we stand by and watch? Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.